CompletedPhase 2NCT01870596
Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- B. Smith, M.S.W., L.C.S.WSidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
- Intervention
- Cytarabine(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2013 – 2014
Study locations (5)
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, Maryland, United States
- Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
- Mayo Clinic, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01870596 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.